Tumor necrosis factor-α and X-linked adrenoleukodystrophy

M. C. Mcguinness, D. E. Griffin, G. V. Raymond, C. A. Washington, H. W. Moser, K. D. Smith

Research output: Contribution to journalArticlepeer-review

49 Scopus citations


The two most common forms of X-linked adrenoleukodystrophy (X-ALD), the childhood cerebral form (CCER) and the adult form, adrenomyeloneuropathy (AMN), arise from the same mutations in the X-ALD gene at Xq28. These two forms are distinguished by the degree of cerebral inflammation. Segregation analysis suggests that an autosomal modifying gene may be a major determinant of phenotype in X-ALD. Thus, a modifying gene could be involved in initiating or promoting the inflammatory response. In this study we detected a difference in tumor necrosis factor-α (TNF-α) bioactivity, but not TNF-α protein levels, in serum from some advanced CCER patients. Early-stage CCER patients and AMN patients were in the normal range. Allelic differences in TNF-α or levels of soluble TNF receptor did not account for bioactivity differences or phenotypic heterogeneity in X-ALD.

Original languageEnglish (US)
Pages (from-to)161-169
Number of pages9
JournalJournal of Neuroimmunology
Issue number2
StatePublished - Sep 1995

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Neurology
  • Clinical Neurology


Dive into the research topics of 'Tumor necrosis factor-α and X-linked adrenoleukodystrophy'. Together they form a unique fingerprint.

Cite this